Unauthorized Use of Content on this Site: The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB)—including, but not limited to, those available through the PAAB Forum, the PAAB website, and any PAAB correspondence—are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content, or using it for model training or any related purposes, is strictly prohibited without the express prior written consent of PAAB. This includes, but is not limited to, the use of such materials in automated systems, machine learning models, or artificial intelligence applications.
PAAB Forum Quarterly Review - Q3/2022
-
Good Afternoon @Manufacturer and @Agency
Summer has wrapped up and ARO is in full swing. Thank you to all our clients for all the great feedback and support as we launched this new service. Click here to see a round up of our Q3 activities.